help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernstrom, J. D.
Right arrow Articles by Kaye, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernstrom, J. D.
Right arrow Articles by Kaye, W. H.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 184-191, Copyright © 1996 by Endocrine Society

ARTICLES

Short-term neuroendocrine effects of a large oral dose of monosodium glutamate in fasting male subjects

JD Fernstrom, JL Cameron, MH Fernstrom, C McConaha, TE Weltzin and WH Kaye
Department of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.

Fasting male subjects received each of four treatments on different days: a large oral dose of monosodium L-glutamate (MSG; 12.7 g), the MSG vehicle, an iv injection of TRH, or a high protein meal. Blood samples were drawn via an indwelling venous line before and at 20-min intervals after each treatment for 4 h. Plasma glutamate levels rose 11- fold within 1 h of MSG ingestion, but did not change appreciably with any of the other treatments. Plasma PRL levels rose 10-fold after TRH infusion and 2-fold after the protein meal, but did not rise significantly after MSG ingestion. No effects resulted from any of the treatments on plasma LH, FSH, testosterone, GH, or cortisol concentrations. Plasma levels of TSH, T4, and T3 showed minimal changes after any of the treatments except TRH; TRH elevated plasma TSH and T3 levels. Self-rating instruments of mood and side-effects revealed no treatment-related effects on mood or physical state for up to 48 h after each treatment. Together, these results suggest that acute pharmacological elevations of plasma glutamate levels in adult men produce minimal, if any, effects on hypothalamic or pituitary function.


This article has been cited by other articles:


Home page
 J. Nutr.Home page
M. Watford
Net Interorgan Transport of L-Glutamate in Rats Occurs via the Plasma, Not via Erythrocytes
J. Nutr., May 1, 2002; 132(5): 952 - 956.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. Walker and J. R. Lupien
The Safety Evaluation of Monosodium Glutamate
J. Nutr., April 1, 2000; 130(4): 1049 - 1049.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
J. D. Fernstrom
Pituitary Hormone Secretion in Normal Male Humans: Acute Responses to a Large, Oral Dose of Monosodium Glutamate
J. Nutr., April 1, 2000; 130(4): 1053 - 1053.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society